Hernia, Ventral Clinical Trial
Official title:
Prospective, Randomized, Double-blind Trial of Continuous Infusion of 0.5% Bupivacaine be Elastomeric Pump for Prospective Pain Management After Laparoscopic Ventral Hernia Repair.
The purpose of this study is to determine the effects of a local anesthetic dispensed via a
tiny catheter device, called the ON-Q PainBuster pump, placed during surgery on top of the
mesh used in the laparoscopic repair of ventral hernias. The goals are:
- reducing postoperative pain from this procedure
- decreasing length of hospital stay
- reducing or eliminating amount of post-operative narcotics used
One outcome of the greater than 2 million abdominal operations performed in the United
States each year is an incisional hernia rate of 3% to 20%. As a result, approximately
150,000 ventral hernia repairs are performed annually. The increasing number of incisional
hernias merely reflects the evolution of surgery with the ability to perform larger
abdominal operations such as aortic surgery and colectomy. Primary tissue repairs have had
unacceptable rates of recurrence when used for larger defects. The introduction of
prosthetic biomaterials revolutionized hernia surgery with the concept of a tension-free
repair. The subsequent rate of recurrence has been lowered to less than 10%. However, the
required dissection of wide areas of soft tissue for mesh placement contribute to an
incidence of wound infections and wound-related complications of 12% or greater. These
problems were part of the impetus to develop minimally invasive techniques for ventral
herniorrhaphy.
The laparoscopic repair of ventral hernias is rapidly evolving with patient and surgeon
interest in less morbid herniorrhaphies and the appeal of minimally invasive surgery. The
technique is based on the open, preperitoneal repair described by Rives and Stoppa. The
placement of a large mesh in the preperitoneal location allows for an even distribution of
forces along the surface area of the mesh, which may account for the strength of the repair
and the decreased recurrence rates associated with it. The minimally invasive approach
embraces the concept that a retromuscular mesh repair may be more durable, although the mesh
is placed one layer deeper on an intact peritoneum in comparison to the open technique. The
technique incorporates other fundamental components of the open repair such as wide mesh
overlap of the defect and the use of transabdominal fixation sutures and spiral tacks to
secure the mesh.
While the laparoscopic approach to ventral hernia repair has been documented as safe and
effective, with low recurrence rates and minimal patient morbidity, some patients complain
of significant post-operative pain for up to 1-3 months after surgery. The exact cause of
this postoperative discomfort has not been clearly elucidated. Several hypotheses exist.
Some feel that the extensive adhesiolysis required for incisional hernia repair causes
significant peritoneal irritation that is exacerbated with the placement of intraperitoneal
mesh. Others implicate the spiral tacks placed through the mesh into the peritoneum as
sources of persistent discomfort. While others feel that the transabdominal fixation sutures
are the localizing site for the accompanying postoperative pain. Transabdominal suture site
pain after laparoscopic ventral hernia repair is not uncommon, and occurred in 23% of
patients in one series.8 The transabdominal fixation suture sites are those incisions where
sutures are placed to secure the mesh placed during laparoscopic ventral hernia repair to
the anterior abdominal wall. The sutures are placed in a "clockwise" manner approximately
every 4 to 5 cm at the periphery of the mesh as well as 5 mm spiral tacks to hold it in
place until fibrocollagenous ingrowth secures the mesh to the abdominal wall. This
persistent abdominal pain has been documented as a minor long-term complication resulting
from laparoscopic ventral hernia repair, but it can be troublesome for patients in the
immediate postoperative period.
The most effective method for managing this postoperative pain has not been defined.
The goal of postoperative care is to minimize the amount of pain a patient experiences
following surgery and to help the patient make a quick recovery that leads to a shorter
hospital stay free of complications and an earlier return to self-reliance. The most common
treatment for pain after operation is opioid analgesic drug administration. Opioids are
associated with undesirable side effects such as respiratory depression, nausea and
vomiting, itching, increased duration of postoperative ileus, and delay in discharge. These
side effects can be decreased with a reduction in the amount of opioid drugs utilized.
Additionally, systemic narcotics may not optimize pain management in a specific region of
the body because of its centralized effect. This may lead to a decreased mentation, reduced
mobility, and a slower return to normal activities. Because a reduction of the daily
consumption of narcotics is often associated with a decrease in analgesia, many other
treatments for postoperative pain have been evaluated. For example, epidural analgesia is
effective but the catheter needs to be placed preoperatively, is fairly invasive method, and
the maintenance of the epidural treatment can be time consuming and expensive. Many studies
have found clinical pain management benefits to the use of local analgesia, as measured by
the use of less post-operative pain medication and more favorable ratings on pain intensity
scales. Recently, a new method of delivering continuous wound infiltration with a solution
of local anesthetic through an indwelling irrigation apparatus has been used in an attempt
to reduce early postoperative discomfort in patients after thoracotomy, donor nephrectomy,
and open inguinal hernia repair. These prospective randomized double blind studies
universally report decreased postoperative discomfort and limited usage of opioids with the
usage of these novel catheters.
In this study, the goal is to minimize postoperative pain so that post-operative narcotic
requirements will be unnecessary or required less frequently. The infusion of a local
anesthetic immediately following the surgical procedure is intended to allow the body
tissues to react more favorably to surgical stress and reduce early postoperative pain.
The primary hypothesis is that continuous infusion of a local anesthetic along the edges of
the mesh near the transabdominal fixation sutures and spiral tacks placed to secure mesh to
the anterior abdominal wall will both subjectively and objectively improve postoperative
pain control following laparoscopic ventral hernia repair. A secondary hypothesis is that
pulmonary function and bowel function postoperatively will recover faster with the use of a
continuous infusion of local anesthetic.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06051578 -
Abdominal Wall Tension in Patients Undergoing Ventral Hernia Repair Without Component Separation
|
||
Recruiting |
NCT04098380 -
Small Versus Large Bite Closure of Emergency Midline Laparotomy
|
N/A | |
Completed |
NCT02616718 -
Incisional Hernia Progression Over Time
|
N/A | |
Completed |
NCT06034652 -
T-GENVIH-003 LTFU (Long Term Follow Up) Study
|
||
Completed |
NCT04222517 -
The Use of Local Hemostatic in Patients With Large Incisional Hernias
|
N/A | |
Completed |
NCT00749268 -
AbsorbaTack Evaluation of Postoperative Pain Following Laparoscopic Hernia Repair
|
Phase 4 | |
Not yet recruiting |
NCT05467124 -
Enhanced Recovery After Abdominal Wall Reconstruction
|
||
Completed |
NCT00472537 -
ProLOVE - Prospective Randomized Study of Midline Incisional Hernia Treatment
|
N/A | |
Active, not recruiting |
NCT02365194 -
Modifying Risk in Ventral Hernia Patients
|
N/A | |
Recruiting |
NCT04718168 -
GORE® ENFORM Biomaterial Product Study
|
N/A | |
Completed |
NCT02594241 -
PreOperative Steroid in Abdominal Wall Reconstruction: A Double-blinded Randomized Clinical Trial
|
N/A | |
Active, not recruiting |
NCT02363790 -
Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial
|
N/A | |
Completed |
NCT02398565 -
Pregnancy Subsequent to Ventral Hernia Repair
|
N/A | |
Terminated |
NCT02041494 -
Complex Ventral Hernia Repair Using Biologic or Synthetic Mesh
|
N/A | |
Completed |
NCT00532870 -
Laparoscopic Intraperitoneal Mesh Repair of Ventral Hernia: Comparison to Conventional Mesh Repair
|
N/A | |
Completed |
NCT05320055 -
Pain and Readmission After Lap IPOM vs. Robotic Ventral Hernia Repair
|
||
Completed |
NCT04229940 -
Peritoneal in Laparoscopic Ventral Hernia Repair 2
|
Phase 2 | |
Completed |
NCT05446675 -
Endoscopic eTEP Versus Open Rives-Stoppa
|
||
Completed |
NCT05912868 -
Endoscopic Mini/Less Open Sublay(EMILOS) Repair
|
||
Not yet recruiting |
NCT06449378 -
Transorbâ„¢ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia
|
N/A |